Celldex Therapeutics reported $22K in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
AbbVie USD 16.99B 1.99B Jun/2026
Agenus USD 33.7M 500K Mar/2026
Amgen USD 10.1B 1.48B Jun/2026
Bristol-Myers Squibb USD 12.97B 1.48B Jun/2026
Celldex Therapeutics USD 22K 7K Jun/2026
Glaxosmithkline GBP 10.09B 1.37B Mar/2026
Nektar Therapeutics USD 10.86M 10.95M Mar/2026
Northwest Biotherapeutics USD 494K 294K Mar/2026
Pfizer USD 15.03B 530M Jun/2026
Rigel Pharmaceuticals USD 55.31M 18.47M Sep/2024
Roche Holding CHF 30.36B 14.71B Jun/2026